| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.52B | 83.80B | 67.22B | 71.88B | 72.92B | 66.08B |
| Gross Profit | 13.35B | 15.85B | 12.56B | 12.71B | 13.69B | 12.13B |
| EBITDA | 5.20B | 6.90B | 4.55B | 5.14B | 6.04B | 5.03B |
| Net Income | 2.83B | 4.17B | 2.41B | 3.06B | 3.53B | 3.33B |
Balance Sheet | ||||||
| Total Assets | 57.16B | 62.40B | 57.74B | 54.74B | 52.81B | 51.71B |
| Cash, Cash Equivalents and Short-Term Investments | 18.79B | 17.73B | 18.15B | 19.64B | 19.46B | 20.72B |
| Total Debt | 653.00M | 529.00M | 707.00M | 0.00 | 0.00 | 4.00M |
| Total Liabilities | 23.28B | 24.43B | 23.17B | 20.70B | 20.68B | 21.10B |
| Stockholders Equity | 33.68B | 37.70B | 34.37B | 33.86B | 31.85B | 30.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.21B | 3.17B | 3.44B | 1.45B | 4.12B |
| Operating Cash Flow | 0.00 | 3.47B | 4.51B | 4.42B | 2.66B | 4.75B |
| Investing Cash Flow | 0.00 | -1.77B | -4.00B | -2.29B | -1.79B | -23.00M |
| Financing Cash Flow | 0.00 | -2.19B | -1.96B | -1.97B | -2.17B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥46.62B | 11.14 | ― | 3.78% | 24.67% | 72.89% | |
67 Neutral | ¥102.64B | 35.34 | ― | 2.01% | 12.66% | 4.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥43.19B | 10.94 | ― | 3.53% | 6.68% | -6.70% | |
63 Neutral | ¥40.53B | 9.30 | ― | 2.26% | 17.46% | 102.48% | |
63 Neutral | ¥41.13B | 12.06 | ― | 5.38% | -24.18% | -32.34% | |
60 Neutral | ¥57.30B | 14.53 | ― | 1.57% | 4.01% | 21.41% |